Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Personalized Neoantigen Cancer Vaccine”

82 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 82 results

Early research (Phase 1)Looking for participantsNCT07067385
What this trial is testing

Personalized mRNA Cancer Vaccine for Gastrointestinal Solid Tumor Treatment

Who this might be right for
Personalized Neoantigen Vaccine in Combination With Anti-PD-1 Inhibitors in Standard Therapy-Failed and Adjuvant TherapyGastrointestinal Tumors
Ruijin Hospital 40
Not applicableLooking for participantsNCT06752044
What this trial is testing

Neoantigen-based Peptide Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After First-line Treatment

Who this might be right for
Advanced NSCLC
The First Affiliated Hospital of Nanchang University 10
Very early researchLooking for participantsNCT05916261
What this trial is testing

Personalized Tumor Vaccines and Pabolizumab in Patients With Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Cancer
Ruijin Hospital 54
Early research (Phase 1)Looking for participantsNCT06019702
What this trial is testing

Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen Alone in Subjects With Advanced Digestive System Neoplasms

Who this might be right for
Digestive System Neoplasms
Sir Run Run Shaw Hospital 20
Very early researchLooking for participantsNCT05916248
What this trial is testing

Combination Therapy of Personalized mRNA-0217 Vaccines and Pembrolizumab in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Ruijin Hospital 34
Not applicableLooking for participantsNCT06751914
What this trial is testing

Neoantigen-based Peptide Vaccine and Conventional Second-line Therapy for CRC Progressed After First-line Treatment

Who this might be right for
Colorectal Cancer (CRC)
The First Affiliated Hospital of Nanchang University 10
Very early researchLooking for participantsNCT06496373
What this trial is testing

Clinical Study of mRNA Vaccine Combined With PD-1 Inhibitor as Adjuvant Therapy for Postoperative Pancreatic Cancer

Who this might be right for
Pancreatic Cancer ResectableChemotherapy-intolerant
Ruijin Hospital 20
Early research (Phase 1)Active Not RecruitingNCT03361852
What this trial is testing

Personalized Neoantigen Cancer Vaccine + Pembrolizumab After Rituximab for Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
Dana-Farber Cancer Institute 20
Testing effectiveness (Phase 2)WithdrawnNCT05153304
What this trial is testing

Personalized Immunotherapy in Adults With Upper Gastrointestinal Tract Cancers

Who this might be right for
Cancer of Gastrointestinal Tract
University of California, San Diego
Early research (Phase 1)Study completedNCT04105582
What this trial is testing

Breast Cancer Neoantigen Vaccination With Autologous Dendritic Cells

Who this might be right for
Breast CancerTriple Negative Breast Cancer
Universidad Nacional de Colombia 5
Early research (Phase 1)Ended earlyNCT03597282
What this trial is testing

A Personal Cancer Vaccine (NEO-PV-01) and APX005M or Ipilimumab With Nivolumab in Patients With Advanced Melanoma

Who this might be right for
Metastatic Melanoma
BioNTech US Inc. 22
Early research (Phase 1)UnknownNCT04487093
What this trial is testing

Clinical Study of Neoantigen Vaccine Combined With Targeted Drugs in the Treatment of Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
First Hospital of Shijiazhuang City 20
Not applicableStudy completedNCT03794128
What this trial is testing

Personalized Neoantigen Cancer Vaccines

Who this might be right for
Non Small Cell Lung CancerColorectal CancerGastroesophageal Adenocarcinoma+2 more
Gritstone bio, Inc. 93
Early research (Phase 1)Study completedNCT03359239
What this trial is testing

Atezolizumab Given in Combination With a Personalized Vaccine in Patients With Urothelial Cancer

Who this might be right for
Urothelial/Bladder Cancer, Nos
Matthew Galsky 10
Not applicableUnknownNCT03908671
What this trial is testing

Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Esophageal Cancer and Non-small Cell Lung Cancer

Who this might be right for
Esophageal CancerNon Small Cell Lung Cancer
Stemirna Therapeutics 24
Early research (Phase 1)UnknownNCT03871205
What this trial is testing

Neoantigen-primed DC Vaccines Therapy for Refractory Lung Cancer

Who this might be right for
Carcinoma, Non-Small Cell LungCarcinoma, Small Cell Lung
Shenzhen People's Hospital 30
Early research (Phase 1)UnknownNCT03662815
What this trial is testing

Clinical Study of a Personalized Neoantigen Cancer Vaccine in Treating Patients With Advanced Malignant Tumor

Who this might be right for
Advanced Malignant Solid Tumor
Sir Run Run Shaw Hospital 30
Not applicableLooking for participantsNCT05749627
What this trial is testing

Using Neoantigen Peptide Vaccine/neoantigen-based DC to Treat Advanced Malignant Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumors
The First Affiliated Hospital of Nanchang University 20
Early research (Phase 1)Active Not RecruitingNCT05743595
What this trial is testing

Neoantigen-based Personalized DNA Vaccine With Retifanlimab PD-1 Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma

Who this might be right for
Unmethylated Glioblastoma
Washington University School of Medicine 27
Early research (Phase 1)Active Not RecruitingNCT02950766
What this trial is testing

NeoVax Plus Ipilimumab in Renal Cell Carcinoma

Who this might be right for
Kidney Cancer
Patrick Ott, MD, PhD 19
Next Page